Keywords: abraxis, appoints, merck, lax, van, der, ploeg

Abraxis appoints Merck's Lax Van der Ploeg as SVP

Article | 26 January 2009

Print This

The USA's Abraxis Bioscience has appointed Lex Van der Ploeg as senior vice president of integrative medicines and translational science. ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in